This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

The U.S. Food and Drug Administration recently approved a new vaccine that will cover more strains of the human papillomavirus virus  (HPV) and have a greater reach at protecting against various cancers, including cervical.

Dr. Dean Blumberg, Chief of Pediatric Infectious Diseases at U.C. Davis Health System discusses the effect of the vaccine.